dengue fever vaccines
ARTICLE FINDER

Congress seeks P1.16-B special budget for Dengvaxia recipients

Mar 21, 2018 - 4:19 PM

(UPDATED) The additional budget, which has been requested by the budget and health departments, will be used to provide medical support, like hospitalization, medical kits, outpatient care services, and laboratory tests

BUDGET. The Department of Budget and Management and Department of Health will request a supplemental budget for Dengvaxia vaccinees. File photo by Aika Rey/Rappler

Dengvaxia issue, Sereno acquittal, Cotto retirement | Evening wRap

Dec 04, 2017 - 9:38 PM

Watch Rappler’s evening newscast with Acor Arceo

FDA orders market pullout of Dengvaxia vaccine

Dec 04, 2017 - 9:10 PM

(UPDATED) The drug regulatory agency also directs pharma giant Sanofi to 'conduct an information dissemination campaign through advisories, Dear Doctor letters, and patient fora'

STOP THE SALE. A health worker shows used vials of Dengvaxia administered to students in Manila before Sanofi gave an update that the vaccine is risky for those who had no prior infection. Photo by Ben Nabong/Rappler

Sanofi can't trace individuals at risk, but continues to monitor Dengvaxia recipients

Dec 04, 2017 - 5:30 PM

Will Sanofi shoulder the costs of individuals who might contract severe dengue after receiving the vaccine? The company only says it is collaborating with the Department of Health.

RISK. A health worker shows off used vials of Dengvaxia vaccine inside the storage facility of the local government health sector that was given to students during the school-based immunisation in Manila on December 4, 2017. Photo by Ben Nabong/Rappler

Sanofi: Dengvaxia not guaranteed to prevent dengue

Dec 04, 2017 - 10:55 AM

(3rd UPDATE) However, when a person gets the vaccine after he has had an infection, the effectivity of the vaccine increases by up to 6 years, says Dr Ng Su Peing, global medical head of Sanofi

RISK. Pharmaceutical companuy Sanofi pasteur issued new findings against it Dengvaxia vaccine. Photo by Rappler

Duque hopes Dengvaxia issue won't deter vaccination for other diseases

Dec 01, 2017 - 3:51 PM

'There are countless number of lives that have been saved from vaccine-preventable diseases,' says Health Secretary Francisco Duque III

VACCINE'S IMPORTANCE. A health officer administers a measles shot on a young girl. File photo by Jose Del/Rappler

More than 700,000 Filipino youth got risky dengue vaccine – DOH

Dec 01, 2017 - 2:47 PM

(UPDATED) The Philippine government spent P3.5 billion on the mass immunization program, funded by sin tax revenues

DENGUE PROBLEM. From L to R: DOH Undersecretary Gerardo Bayugo, DOH Secretary Francisco Duque III, and WHO's Dr Rajendra Yadav hold a press conference on December 1. Photo by Mara Cepeda/Rappler

DOH suspends dengue vaccination program

Dec 01, 2017 - 11:52 AM

(2nd UPDATE) Health Secretary Francisco Duque III temporarily halts the program after Dengvaxia maker Sanofi Pasteur said its product poses higher risks to people without prior infection

DENGVAXIA. The world's first anti-dengue vaccine is administered to Filipino grade-schoolers under the government's school-based dengue immunization program. File photo by Joel Liporada/Rappler

Vaccinated Filipino youth now at risk of getting severe dengue

Nov 30, 2017 - 5:02 PM

After Sanofi Pasteur's advisory on Dengvaxia, Dr Anthony Leachon says students who already got their dengue shots from DOH will live with the possibility of getting severe dengue 'for the rest of their lives'

SCHOOL-BASED IMMUNIZATION. A student from Parang Elementary School gets a shot of Dengvaxia, the world's first-ever dengue vaccine. File photo by Ben Nabong/Rappler

Dengue vaccine more risky for people without prior infection – Sanofi

Nov 30, 2017 - 11:12 AM

Philippine Health Secretary Francisco Duque III says the 'safety of Filipino children' is the prime consideration as health officials meet on the implications of Sanofi Pasteur's advisory on Dengvaxia

DENGVAXIA. Photo by Joel Liporada/Rappler